bioMérieux S.A. (EPA:BIM)
France flag France · Delayed Price · Currency is EUR
86.85
-0.40 (-0.46%)
Oct 19, 2026, 5:35 PM CET

bioMérieux Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, bioMérieux stock has a consensus rating of "Hold" and an average price target of €79.90. The average 1-year stock price forecast is 8.00% lower than the current stock price, while the lowest is €71.00 (-18.25%) and the highest is €100.00 (+15.14%).

Price Target: €79.90 (-8.00%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price€71.00€79.90€80.00€100.00
Change-18.25%-8.00%-7.89%+15.14%
* Price targets were last updated on Sep 11, 2026.

Analyst Ratings

The average analyst rating for bioMérieux stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy333333
Buy111111
Hold899999
Sell000000
Strong Sell011111
Total121414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Sell
Maintains
€64.00 → €66.00
SellMaintains€64.00 → €66.00-24.01%Sep 11, 2026
Barclays
Barclays
Hold
Maintains
€75.00 → €80.00
HoldMaintains€75.00 → €80.00-7.89%Sep 7, 2026
Deutsche Bank
Deutsche Bank
Hold
Maintains
€78.00 → €75.00
HoldMaintains€78.00 → €75.00-13.64%Jul 30, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
€80.00
HoldReiterates€80.00-7.89%Jul 29, 2026
UBS
UBS
Hold
Maintains
€80.00 → €78.00
HoldMaintains€80.00 → €78.00-10.19%Jul 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.13B
from 4.07B
Increased by 1.52%
Revenue Next Year
4.35B
from 4.13B
Increased by 5.32%
EPS This Year
4.35
from 4.64
Decreased by -6.28%
EPS Next Year
4.67
from 4.35
Increased by 7.44%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.38B3.59B3.67B3.98B4.07B4.13B
Revenue Growth
8.27%6.31%2.39%8.31%2.26%1.52%
Gross Profit
2.00B2.01B2.06B2.22B2.31B2.31B
Gross Margin
59.26%55.97%55.99%55.66%56.73%55.79%
Operating Income
813.50M613.00M569.00M637.90M694.80M665.17M
Net Income
601.10M452.40M357.60M432.20M397.50M485.37M
EPS
----4.644.35
EPS Growth
----22.16%-6.28%
Forward PE
31.2525.4823.6023.0522.6219.97
Dividend / Share
0.850.850.850.900.981.05
Dividend Growth
37.10%--5.88%8.89%7.31%
Free Cash Flow
----462.40M464.15M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High4.2B
Avg4.1B
Low4.1B

Revenue Growth

Revenue Growth202620272028
High
3.2%
Avg
1.5%
Low
0.6%

EPS Forecast

EPS202620272028
High4.59
Avg4.35
Low4.04

EPS Growth

EPS Growth202620272028
High
-1.1%
Avg
-6.3%
Low
-12.9%